Federal Panel Recommends Shingles Vaccination for Adults 60 and Older
A federal advisory committee has recommended that adults aged 60 and older receive a new shingles vaccine. The Advisory Committee on Immunization Practices made the recommendation to reduce the risk of herpes zoster, commonly known as shingles. Shingles can cause chronic pain.
Advertisement
Atlanta — The Advisory Committee on Immunization Practices (ACIP) recommended a shingles vaccine for adults aged 60 and older. The ACIP, a panel of immunization experts, advises federal agencies.
The committee cited the vaccine's potential to prevent herpes zoster as the primary reason for the recommendation. Herpes zoster, also known as shingles, can lead to chronic pain in some individuals. The vaccine targets the varicella-zoster virus, which also causes chickenpox.
Shingles presents as a painful rash, typically on one side of the body. The condition arises from a reactivation of the varicella-zoster virus in individuals who previously had chickenpox. According to the Centers for Disease Control and Prevention, almost one out of every three people in the United States will develop shingles in their lifetime.
The ACIP regularly reviews and updates vaccine recommendations based on scientific data. These recommendations influence vaccine schedules and coverage policies nationwide. Recommendations from the ACIP are reviewed by the CDC and often adopted as guidelines for healthcare providers.
Related Topics
Article Ratings
How do you feel about this story?
National Desk
Sign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!